{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:21:00Z","timestamp":1784593260373,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008456","name":"A. Alfred Taubman Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008456","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P50- AR070590"],"award-info":[{"award-number":["P50- AR070590"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30-AR075043"],"award-info":[{"award-number":["P30-AR075043"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01-AR060802"],"award-info":[{"award-number":["R01-AR060802"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01-AR071384"],"award-info":[{"award-number":["R01-AR071384"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100003185","name":"National Psoriasis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100003185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jid.2021.05.029","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T11:02:14Z","timestamp":1628161334000},"page":"155-165.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["IFN-\u03ba Is a Rheostat for Development of Psoriasiform Inflammation"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2177-2427","authenticated-orcid":false,"given":"Mehrnaz","family":"Gharaee-Kermani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9225-6729","authenticated-orcid":false,"given":"Shannon N.","family":"Estadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-5722","authenticated-orcid":false,"given":"Lam C.","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3626-9274","authenticated-orcid":false,"given":"Sonya J.","family":"Wolf-Fortune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3585-6557","authenticated-orcid":false,"given":"Jianhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-6868","authenticated-orcid":false,"given":"Xianying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4912-6638","authenticated-orcid":false,"given":"Jonathon","family":"Theros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0831-5296","authenticated-orcid":false,"given":"Tamra J.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2359-8426","authenticated-orcid":false,"given":"Lori","family":"Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5169-5100","authenticated-orcid":false,"given":"Dennis","family":"Gruszka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1907-2621","authenticated-orcid":false,"given":"Nicole L.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0080-0812","authenticated-orcid":false,"given":"Johann E.","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-8945","authenticated-orcid":false,"given":"J. Michelle","family":"Kahlenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2021.05.029_bib2","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1016\/j.jid.2019.08.437","article-title":"Psoriasis: past, present, and future","volume":"139","author":"Billi","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.05.029_bib4","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3389\/fimmu.2018.01390","article-title":"T\u00a0cell hierarchy in the pathogenesis of psoriasis and associated cardiovascular comorbidities","volume":"9","author":"Casciano","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2021.05.029_bib5","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2015.08.005","article-title":"Epidermal injury promotes nephritis flare in lupus-prone mice","volume":"65","author":"Clark","year":"2015","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2021.05.029_bib6","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1172\/JCI29441","article-title":"Misbehaving macrophages in the pathogenesis of psoriasis","volume":"116","author":"Clark","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2021.05.029_bib7","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I interferon in the pathogenesis of lupus","volume":"192","author":"Crow","year":"2014","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.05.029_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaci.2015.10.046","article-title":"Targeting CD8(+) T cells prevents psoriasis development","volume":"138","author":"Di Meglio","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2021.05.029_bib9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00109-016-1421-4","article-title":"Cause and consequences of the activated type I interferon system in SLE","volume":"94","author":"Eloranta","year":"2016","journal-title":"J\u00a0Mol Med (Berl)"},{"key":"10.1016\/j.jid.2021.05.029_bib10","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.1916897117","article-title":"Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus","volume":"117","author":"Goel","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.05.029_bib11","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.1403015","article-title":"Dual inhibition of TNFR1 and IFNAR1 in imiquimod-induced psoriasiform skin inflammation in mice","volume":"194","author":"Grine","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.05.029_bib12","doi-asserted-by":"crossref","first-page":"20134","DOI":"10.1038\/srep20134","article-title":"Topical imiquimod yields systemic effects due to unintended oral uptake","volume":"6","author":"Grine","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2021.05.029_bib13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clindermatol.2013.11.001","article-title":"Psoriasis as a systemic disease","volume":"32","author":"Grozdev","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jid.2021.05.029_bib14","doi-asserted-by":"crossref","first-page":"7480","DOI":"10.4049\/jimmunol.162.12.7480","article-title":"IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder","volume":"162","author":"Hong","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.05.029_bib15","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2021.05.029_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.142067","article-title":"Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin","volume":"5","author":"Jiang","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2021.05.029_bib17","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","article-title":"Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation","volume":"190","author":"Johnston","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.05.029_bib18","doi-asserted-by":"crossref","first-page":"13466","DOI":"10.1038\/ncomms13466","article-title":"IL-12 protects from psoriasiform skin inflammation","volume":"7","author":"Kulig","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.05.029_bib19","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jid.2019.12.008","article-title":"Tussilagonone ameliorates psoriatic features in keratinocytes and imiquimod-induced psoriasis-like lesions in mice via NRF2 activation","volume":"140","author":"Lee","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.05.029_bib20","doi-asserted-by":"crossref","first-page":"117231","DOI":"10.1016\/j.lfs.2019.117231","article-title":"PSORI-CM02 formula alleviates imiquimod-induced psoriasis via affecting macrophage infiltration and polarization","volume":"243","author":"Li","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.jid.2021.05.029_bib21","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2147\/CCID.S218243","article-title":"Interferon kappa is up-regulated in psoriasis and it up-regulates psoriasis-associated cytokines in\u00a0vivo","volume":"12","author":"Li","year":"2019","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.jid.2021.05.029_bib23","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and\u00a0dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jid.2021.05.029_bib24","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jid.2021.05.029_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.05.029_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2021.05.029_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-pathol-011811-132448","article-title":"Psoriasis","volume":"7","author":"Perera","year":"2012","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.jid.2021.05.029_bib28","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jaad.2011.12.018","article-title":"Preliminary clinical activity of a topical JAK1\/2 inhibitor in the treatment of psoriasis","volume":"67","author":"Punwani","year":"2012","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2021.05.029_bib52","doi-asserted-by":"crossref","first-page":"213197","DOI":"10.1136\/annrheumdis-2018-213197","article-title":"Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa","volume":"77","author":"Sarkar","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2021.05.029_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/jir.2006.26.133","article-title":"Analysis of IFN-kappa expression in pathologic skin conditions: downregulation in psoriasis and atopic dermatitis","volume":"26","author":"Scarponi","year":"2006","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.jid.2021.05.029_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41584-019-0175-0","article-title":"Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition","volume":"15","author":"Scher","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jid.2021.05.029_bib32","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1038\/ncomms8687","article-title":"Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from \u03b3\u03b4-T cells","volume":"6","author":"Shibata","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2021.05.029_bib33","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.4049\/jimmunol.1101313","article-title":"Type I IFN drives a distinctive dendritic cell maturation phenotype that allows continued class II MHC synthesis and antigen processing","volume":"188","author":"Simmons","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.05.029_bib34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13073-017-0415-3","article-title":"Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis","volume":"9","author":"Swindell","year":"2017","journal-title":"Genome Med"},{"key":"10.1016\/j.jid.2021.05.029_bib35","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.4049\/jimmunol.1800650","article-title":"Hypersensitive IFN responses in lupus keratinocytes reveal key mechanistic determinants in cutaneous lupus","volume":"202","author":"Tsoi","year":"2019","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.05.029_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13059-014-0570-4","article-title":"Analysis of long non-coding RNAs highlights tissue-specific expression patterns and epigenetic profiles in normal and psoriatic skin","volume":"16","author":"Tsoi","year":"2015","journal-title":"Genome Biol"},{"key":"10.1016\/j.jid.2021.05.029_bib37","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jid.2018.12.018","article-title":"Atopic dermatitis is an IL-13\u2013dominant disease with greater molecular heterogeneity compared to psoriasis","volume":"139","author":"Tsoi","year":"2019","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.05.029_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1346-8138.12367","article-title":"Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod","volume":"41","author":"Ueyama","year":"2014","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2021.05.029_bib39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.0022-202X.2003.22113.x","article-title":"In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered [published correction appears in J Invest Dermatol 2004;123:415]","volume":"122","author":"van der Fits","year":"2004","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2021.05.029_bib40","doi-asserted-by":"crossref","first-page":"10723","DOI":"10.1073\/pnas.1307569110","article-title":"Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice","volume":"110","author":"Wohn","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2021.05.029_bib41","doi-asserted-by":"crossref","first-page":"102291","DOI":"10.1016\/j.jaut.2019.06.002","article-title":"Ultraviolet light induces increased T cell activation in lupus-prone mice via type I IFN-dependent inhibition of T regulatory cells","volume":"103","author":"Wolf","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jid.2021.05.029_bib42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4049\/jimmunol.1701588","article-title":"TLR7-mediated lupus nephritis is independent of type I IFN signaling","volume":"201","author":"Wolf","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.05.029_bib43","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2353\/ajpath.2009.080858","article-title":"Keratinocyte but not endothelial cell-specific overexpression of Tie2 leads to the development of psoriasis","volume":"174","author":"Wolfram","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2021.05.029_bib44","doi-asserted-by":"crossref","first-page":"5863","DOI":"10.4049\/jimmunol.176.10.5863","article-title":"Increased expression of Ifi202, an IFN-activatable gene, in B6.Nba2 lupus susceptible mice inhibits p53-mediated apoptosis","volume":"176","author":"Xin","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2021.05.029_bib45","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1189\/jlb.3HI0914-453R","article-title":"Differential effects of IFN-\u03b2 on IL-12, IL-23, and IL-10 expression in TLR-stimulated dendritic cells","volume":"98","author":"Yen","year":"2015","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.jid.2021.05.029_bib46","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1084\/jem.20150376","article-title":"IL-23 induced in keratinocytes by endogenous TLR4 ligands polarizes dendritic cells to drive IL-22 responses to skin immunization","volume":"213","author":"Yoon","year":"2016","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2021.05.029_bib47","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3389\/fimmu.2019.01440","article-title":"Type1 interferons potential initiating factors linking skin wounds with psoriasis pathogenesis","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2021.05.029_bib48","doi-asserted-by":"crossref","first-page":"e127291","DOI":"10.1172\/jci.insight.127291","article-title":"The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity","volume":"4","author":"Billi","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2021.05.029_bib49","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1172\/JCI133159","article-title":"KLK6 expression in skin induces PAR1-mediated psoriasiform dermatitis and inflammatory joint disease","volume":"130","author":"Billi","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jid.2021.05.029_bib50","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/art.40166","article-title":"Enhanced inflammasome activity in systemic lupus erythematosus is mediated via type I interferon-induced up-regulation of interferon regulatory factor 1","volume":"69","author":"Liu","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2021.05.029_bib51","doi-asserted-by":"crossref","first-page":"eaav7561","DOI":"10.1126\/scitranslmed.aav7561","article-title":"IFN-\u03b3 enhances cell-mediated cytotoxicity against keratinocytes via JAK2\/STAT1 in lichen planus","volume":"11","author":"Shao","year":"2019","journal-title":"Sci Transl Med"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21014524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X21014524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:48:23Z","timestamp":1762206503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X21014524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0022202X21014524"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2021.05.029","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFN-\u03ba Is a Rheostat for Development of Psoriasiform Inflammation","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2021.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}